Search Results - Robert Rissmann

The impact of CYP2C19 genotype on phenoconversion by concomitant medication by Laura M. de Jong, Soukayna Boussallami, Elena Sánchez-López, Martin Giera, Maarten E. Tushuizen, Menno Hoekstra, Lukas J. A. C. Hawinkels, Robert Rissmann, Robert Rissmann, Robert Rissmann, Jesse J. Swen, Martijn L. Manson

Connect to this object online.

Anti-IL-17A blockade did not significantly reduce inflammatory lesions in a placebo-controlled pilot study in adult patients with moderate to severe acne by Diane M. Thiboutot, Noah Craft, Robert Rissmann, Ewa Gatlik, Malika Souquières, Julie Jones, Christian Loesche

Connect to this object online.

Antimicrobial Peptide Omiganan Enhances Interferon Responses to Endosomal Toll‐Like Receptor Ligands in Human Peripheral Blood Mononuclear Cells by Hendrika W. Grievink, Silvana M. G. Jirka, Tess D. Woutman, Mascha Schoonakker, Robert Rissmann, Karen E. Malone, Gary Feiss, Matthijs Moerland

Connect to this object online.

The oral IRAK4 inhibitors zabedosertib and BAY1830839 suppress local and systemic immune responses in a randomized trial in healthy male volunteers by Stefan J. Jodl, Wouter tenVoorde, Stefan Klein, Andrea Wagenfeld, Frank S. Zollmann, Maximilian Feldmüller, Naomi B. Klarenbeek, Digna T. deBruin, Manon A. A. Jansen, Robert Rissmann, Beate Rohde, Matthijs Moerland

Connect to this object online.

Omiganan Enhances Imiquimod‐Induced Inflammatory Responses in Skin of Healthy Volunteers by Tessa Niemeyer‐van der Kolk, Salma Assil, Thomas P. Buters, Melanie Rijsbergen, Erica S. Klaassen, Gary Feiss, Edwin Florencia, Errol P. Prens, Jacobus Burggraaf, Martijn B.A. vanDoorn, Robert Rissmann, Matthijs Moerland

Connect to this object online.

Intradermal substance P as a challenge agent in healthy individuals by Wouter tenVoorde, Chika Akinseye, Ismahaan Abdisalaam, Selinde Wind, Naomi Klarenbeek, Menthe Bergmans, Martijn vanDoorn, Robert Rissmann, Rejbinder Kaur, Sarah Hotee, Katie Foster, Arati Nair, Lea Fortunato, Colin Macphee, Sarah Mole, Katrine Baumann, Richard Brigandi

Connect to this object online.

Pharmacodynamic Effects of Topical Omiganan in Patients With Mild to Moderate Atopic Dermatitis in a Randomized, Placebo‐Controlled, Phase II Trial by Tessa Niemeyer‐van der Kolk, Hein van derWall, Geretta K. Hogendoorn, Rianne Rijneveld, Sascha Luijten, Dirk C.J.G. vanAlewijk, Ellen H.A. van denMunckhof, Marieke L. deKam, Gary L. Feiss, Errol P. Prens, Jacobus Burggraaf, Robert Rissmann, Martijn B.A. vanDoorn

Connect to this object online.

Inter- and Intra-patient Variability Over Time of Lesional Skin Microbiota in Adult Patients with Atopic Dermatitis by Ellen H.A. van den Munckhof, Tessa Niemeyer-van der Kolk, Hein van der Wall, Dirk C.J.G. van Alewijk, Martijn B.A. van Doorn, Jacobus Burggraaf, Thomas P. Buters, Martin J. Becker, Gary L. Feiss, Wim G.V. Quint, Leen-Jan van Doorn, Cornelis W. Knetsch, Robert Rissmann

Connect to this object online.